科華數據(002335.SZ)半年度淨利潤預增65%-100%
格隆匯7月13日丨科華數據(002335.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤17828.1萬元-21609.82萬元,同比增長65%-100%。
公司2021年半年度業績實現同比上升,主要系公司數據中心、新能源及智慧電能業務穩健增長。在“雙碳”目標及數字經濟背景下,公司以市場為導向,依託33年積累的技術創新與卓越供應鏈管理能力,發揮“技術領先的高品質綠色數據中心綜合服務提供商”、“高可靠的光儲專家”及“智慧電能綜合管理解決方案提供商”的優勢,實現公司經營業績穩步增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.